Individualizing T2DM Treatment: Determining Optimal Pathways that Lead to Achieving Target Goals |
||
![]() CME Program from The Doctor's Channel Individualizing T2DM Treatment: Determining Optimal Pathways that Lead to Achieving Target Goals will review how to examine the differences in mechanism of action, efficacy, and safety of treatment options that target the incretin pathway. The on-demand interviews also talk about how to incorporate evidence-based guidelines and recommendations into practice when considering the use of incretin-based therapies for type 2 diabetes. |